藥華藥 (6446)
藥華藥 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$2.64B, up 100.0% from a year earlier. EPS over the last four quarters totals NT$18.69.
Company profile
Data as of 2026-10-18
- Market
- TWSE-listed
- Industry
- Biotech & Medical Care
- Listed
- 2024-01-25
- Founded
- 2000-05-09
- Paid-in capital
- NT$4.22B
- Common shares issued
- 422,434,636
- Legal name
- 藥華醫藥股份有限公司
- Website
- http://www.PharmaEssentia.com
Monthly revenue
Data as of 2026-10-17
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$2.64B | +0.7% | +100.0% |
| 2026-08 | NT$2.62B | +4.4% | +105.4% |
Year to date: +83.5% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | 5.56 |
| 2026 Q1 | 5.79 |
| 2025 Q4 | 3.98 |
| 2025 Q3 | 3.36 |
| 2025 Q2 | 2.50 |
| 2025 Q1 | 3.80 |
| 2024 Q4 | 3.73 |
| 2024 Q3 | 2.18 |
Last four quarters: NT$18.69
Dividends
Data as of 2026-10-18
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 1.50 | 1.10 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 58,082 | 1.4% |
| 1,000–5,000 shares | 12,646 | 6.0% |
| 5,001–10,000 shares | 2,162 | 3.7% |
| 10,001–15,000 shares | 909 | 2.6% |
| 15,001–20,000 shares | 491 | 2.0% |
| 20,001–30,000 shares | 509 | 2.9% |
| 30,001–40,000 shares | 316 | 2.6% |
| 40,001–50,000 shares | 186 | 2.0% |
| 50,001–100,000 shares | 406 | 6.7% |
| 100,001–200,000 shares | 197 | 6.5% |
| 200,001–400,000 shares | 117 | 7.4% |
| 400,001–600,000 shares | 47 | 5.3% |
| 600,001–800,000 shares | 31 | 5.1% |
| 800,001–1,000,000 shares | 18 | 3.7% |
| 1,000,001+ shares | 60 | 42.1% |
TDCC data for 2026-10-16: 60 holders own more than 1,000 lots (42.1% of shares), and 58,082 hold less than one lot (1.4%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | -564 | 11 | 5 | -548 |
| 2026-10-16 | -246 | 247 | 25 | 26 |
| 2026-10-15 | 683 | 123 | 97 | 903 |
| 2026-10-14 | 81 | 26 | 3 | 110 |
| 2026-10-13 | -4 | 39 | 25 | 60 |
| 2026-10-12 | -133 | 20 | 17 | -96 |
| 2026-10-08 | -171 | 20 | -3 | -154 |
| 2026-10-07 | 285 | 29 | 7 | 321 |
| 2026-10-06 | -117 | -2 | -42 | -161 |
| 2026-10-05 | 468 | -1 | 42 | 509 |
| 2026-10-02 | -247 | -20 | 4 | -263 |
| 2026-10-01 | -692 | -53 | 13 | -732 |
| 2026-09-30 | 2 | -4 | 5 | 3 |
| 2026-09-29 | 51 | 0 | -106 | -55 |
| 2026-09-24 | -422 | -16 | 1 | -437 |
| 2026-09-23 | -533 | 16 | 65 | -452 |
| 2026-09-22 | -212 | -50 | 38 | -224 |
| 2026-09-21 | -626 | 3 | -15 | -638 |
| 2026-09-18 | -9,222 | 8,555 | 28 | -639 |
| 2026-09-17 | -530 | 2 | 18 | -510 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net sellers of 2,977 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$1,175.00 (2026-10-19); 52-week range NT$452.50–1,645.00.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.